ChinaA 148-child trial found 0.01% atropine reduced transient myopia.
Nearwork-induced transient myopia is blurred distance vision after close work, linked to higher myopia progression risk.
The journal Eye published a trial giving myopic children aged 6-15 nightly atropine or placebo for 12 weeks, then 12 weeks’ observation.
Adverse events hit 37.0% on atropine and 41.7% on placebo, with none serious.
The trial did not measure long-term myopia progression, the outcome low-dose atropine is mainly prescribed to slow.
How each outlet framed it
- Nature
- measures 0.01% atropine efficacy in reducing nearwork-induced transient myopia via randomized trial, quantifies improvement at week 2 and week 12 versus placebo
Sources: Nature